SpectronRx

About SpectronRx

SpectronRx specializes in regulatory consulting and end-to-end radiopharmaceutical development, offering CDMO/RDMO services, regulatory assistance, and isotope labeling with a global logistics network. The company provides expertise in mAb, Nanobody, and peptide labeling with a wide range of isotopes and a focus on radiotherapy, competing internationally to support FDA filings, IND holding, and facilities design. With multiple cleanroom facilities and a strong emphasis on cold chain custody, SpectronRx supports early-stage to commercialization programs from discovery through regulatory approval, primarily based in the United States with global reach. Their team includes PhDs in radiochemistry and leaders in isotope procurement, delivering white-glove, end-to-end solutions for drug development and delivery.